Skip to main content
Erschienen in: Obesity Surgery 5/2019

02.02.2019 | Original Contributions

A Novel Full Sense Device to Treat Obesity in a Porcine Model: Preliminary Results

verfasst von: Jung-Hoon Park, Nader Bakheet, Hee Kyong Na, Jae Yong Jeon, Sung Hwan Yoon, Kun Yung Kim, Wang Zhe, Do Hoon Kim, Hwoon-Yong Jung, Ho-Young Song

Erschienen in: Obesity Surgery | Ausgabe 5/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To evaluate the technical feasibility, safety, and efficacy of a novel full sense device (FSD) for the treatment of obesity in a porcine model.

Materials and Methods

The novel FSD comprised a self-expanding metallic esophageal stent connected to a star-shaped nitinol disk. Three types of FSD were used: fully covered (type A), fully covered with barbs (type B), and uncovered with barbs (type C). Nine juvenile pigs were divided into two groups: FSD (n = 6) and control (n = 3). FSD type A was placed in the FSD group. In case of migration, either FSD type B or type C was then randomly placed. Food intake was monitored daily. Weight changes and ghrelin hormone levels were monitored weekly for 12 weeks.

Results

FSD placement was technically successful in all pigs. All FSDs except one migrated to the stomach within 1 week after placement. The pig in which the FSD was retained showed decreased food intake in the first week after FSD placement, and there was a difference in the final weight between the FSD pig and control pigs. The percentage of weight gain was 116.6% in the control group and 105.3% in the FSD pig.

Conclusion

FSD placement under fluoroscopic and endoscopic guidance is technically feasible and safe in a porcine model. The uncovered FSD appears to decrease food intake and reduce the rate of weight gain. However, the high FSD migration rate is not encouraging.
Literatur
1.
Zurück zum Zitat Tammaro P, Hansel B, Police A, et al. Laparoscopic adjustable gastric banding: predictive factors for weight loss and band removal after more than 10 years’ follow-up in a single university unit. World J Surg. 2017;41(8):2078–86.CrossRefPubMed Tammaro P, Hansel B, Police A, et al. Laparoscopic adjustable gastric banding: predictive factors for weight loss and band removal after more than 10 years’ follow-up in a single university unit. World J Surg. 2017;41(8):2078–86.CrossRefPubMed
2.
Zurück zum Zitat Nguyen NT, Varela JE. Bariatric surgery for obesity and metabolic disorders: state of the art. Nat Rev Gastroenterol Hepatol. 2017;14(3):160–9.CrossRefPubMed Nguyen NT, Varela JE. Bariatric surgery for obesity and metabolic disorders: state of the art. Nat Rev Gastroenterol Hepatol. 2017;14(3):160–9.CrossRefPubMed
3.
Zurück zum Zitat Force ABET, Committee AT, Abu Dayyeh BK, et al. ASGE bariatric endoscopy task force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies. Gastrointest Endosc. 2015;82(3):425–38 e5.CrossRef Force ABET, Committee AT, Abu Dayyeh BK, et al. ASGE bariatric endoscopy task force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies. Gastrointest Endosc. 2015;82(3):425–38 e5.CrossRef
4.
Zurück zum Zitat Saunders KH, Igel LI, Saumoy M, et al. Devices and endoscopic bariatric therapies for obesity. Curr Obes Rep. 2018;7(2):162–71.CrossRefPubMed Saunders KH, Igel LI, Saumoy M, et al. Devices and endoscopic bariatric therapies for obesity. Curr Obes Rep. 2018;7(2):162–71.CrossRefPubMed
6.
Zurück zum Zitat Myall P New endoscopic stent can lead to 100% EWL [Internet] London: Bariatric News; c2012 [updated 2012 Jun 5; cited 2018 july 7] Available from: wwwbariatricnewsnet/?q=node/102. Myall P New endoscopic stent can lead to 100% EWL [Internet] London: Bariatric News; c2012 [updated 2012 Jun 5; cited 2018 july 7] Available from: wwwbariatricnewsnet/?q=node/102.
7.
Zurück zum Zitat Na HK, Song HY, Yeo HJ, et al. Retrospective comparison of internally and externally covered retrievable stent placement for patients with benign urethral strictures caused by traumatic injury. AJR Am J Roentgenol. 2012;198(1):W55–61.CrossRefPubMed Na HK, Song HY, Yeo HJ, et al. Retrospective comparison of internally and externally covered retrievable stent placement for patients with benign urethral strictures caused by traumatic injury. AJR Am J Roentgenol. 2012;198(1):W55–61.CrossRefPubMed
8.
Zurück zum Zitat Steinert RE, Feinle-Bisset C, Asarian L, et al. Ghrelin, CCK, GLP-1, and PYY(3-36): secretory controls and physiological roles in eating and glycemia in health, obesity, and after RYGB. Physiol Rev. 2017;97(1):411–63.CrossRefPubMed Steinert RE, Feinle-Bisset C, Asarian L, et al. Ghrelin, CCK, GLP-1, and PYY(3-36): secretory controls and physiological roles in eating and glycemia in health, obesity, and after RYGB. Physiol Rev. 2017;97(1):411–63.CrossRefPubMed
9.
Zurück zum Zitat Camilleri M. Peripheral mechanisms in appetite regulation. Gastroenterology. 2015;148(6):1219–33.CrossRefPubMed Camilleri M. Peripheral mechanisms in appetite regulation. Gastroenterology. 2015;148(6):1219–33.CrossRefPubMed
11.
Zurück zum Zitat Brookes SJ, Spencer NJ, Costa M, et al. Extrinsic primary afferent signalling in the gut. Nat Rev Gastroenterol Hepatol. 2013;10(5):286–96.CrossRefPubMed Brookes SJ, Spencer NJ, Costa M, et al. Extrinsic primary afferent signalling in the gut. Nat Rev Gastroenterol Hepatol. 2013;10(5):286–96.CrossRefPubMed
12.
Zurück zum Zitat Ionut V, Burch M, Youdim A, et al. Gastrointestinal hormones and bariatric surgery-induced weight loss. Obesity. 2013;21(6):1093–103.CrossRefPubMed Ionut V, Burch M, Youdim A, et al. Gastrointestinal hormones and bariatric surgery-induced weight loss. Obesity. 2013;21(6):1093–103.CrossRefPubMed
13.
Zurück zum Zitat Sharma P, Kozarek R. Practice Parameters Committee of American College of G. Role of esophageal stents in benign and malignant diseases. Am J Gastroenterol 2010;105(2):258–273; quiz 74. Sharma P, Kozarek R. Practice Parameters Committee of American College of G. Role of esophageal stents in benign and malignant diseases. Am J Gastroenterol 2010;105(2):258–273; quiz 74.
14.
Zurück zum Zitat Spaander MC, Baron TH, Siersema PD, et al. Esophageal stenting for benign and malignant disease: European Society of Gastrointestinal Endoscopy (ESGE) clinical guideline. Endoscopy. 2016;48(10):939–48.CrossRefPubMed Spaander MC, Baron TH, Siersema PD, et al. Esophageal stenting for benign and malignant disease: European Society of Gastrointestinal Endoscopy (ESGE) clinical guideline. Endoscopy. 2016;48(10):939–48.CrossRefPubMed
15.
Zurück zum Zitat Kim KY, Tsauo J, Song HY, et al. Self-expandable metallic stent placement for the palliation of esophageal cancer. J Korean Med Sci. 2017;32(7):1062–71.CrossRefPubMedPubMedCentral Kim KY, Tsauo J, Song HY, et al. Self-expandable metallic stent placement for the palliation of esophageal cancer. J Korean Med Sci. 2017;32(7):1062–71.CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Yang J, Siddiqui AA, Kowalski TE, et al. Esophageal stent fixation with endoscopic suturing device improves clinical outcomes and reduces complications in patients with locally advanced esophageal cancer prior to neoadjuvant therapy: a large multicenter experience. Surg Endosc. 2017;31(3):1414–9.CrossRefPubMed Yang J, Siddiqui AA, Kowalski TE, et al. Esophageal stent fixation with endoscopic suturing device improves clinical outcomes and reduces complications in patients with locally advanced esophageal cancer prior to neoadjuvant therapy: a large multicenter experience. Surg Endosc. 2017;31(3):1414–9.CrossRefPubMed
17.
Zurück zum Zitat Watanabe K, Hikichi T, Nakamura J, et al. Feasibility of esophageal stent fixation with an over-the-scope-clip for malignant esophageal strictures to prevent migration. Endoscopy International Open. 2017;5(11):E1044–E9.CrossRefPubMedPubMedCentral Watanabe K, Hikichi T, Nakamura J, et al. Feasibility of esophageal stent fixation with an over-the-scope-clip for malignant esophageal strictures to prevent migration. Endoscopy International Open. 2017;5(11):E1044–E9.CrossRefPubMedPubMedCentral
Metadaten
Titel
A Novel Full Sense Device to Treat Obesity in a Porcine Model: Preliminary Results
verfasst von
Jung-Hoon Park
Nader Bakheet
Hee Kyong Na
Jae Yong Jeon
Sung Hwan Yoon
Kun Yung Kim
Wang Zhe
Do Hoon Kim
Hwoon-Yong Jung
Ho-Young Song
Publikationsdatum
02.02.2019
Verlag
Springer US
Erschienen in
Obesity Surgery / Ausgabe 5/2019
Print ISSN: 0960-8923
Elektronische ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-018-03692-5

Weitere Artikel der Ausgabe 5/2019

Obesity Surgery 5/2019 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.